Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.3%

1 terminated/withdrawn out of 30 trials

Success Rate

96.4%

+9.9% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

33%

9 of 27 completed trials have results

Key Signals

1 recruiting9 with results

Enrollment Performance

Analytics

Phase 1
22(73.3%)
Phase 2
4(13.3%)
N/A
2(6.7%)
Phase 3
2(6.7%)
30Total
Phase 1(22)
Phase 2(4)
N/A(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT05926258Phase 3Completed

Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population

Role: collaborator

NCT07199543Phase 1Completed

Palatability Study of Five Formulations of Benzydamine HCl Lozenges

Role: collaborator

NCT06650631Not ApplicableRecruiting

The Effectiveness of Heat Treatment on Knee Pain in Patients With Osteoarthritis - an International, Multicenter Clinical Investigation

Role: collaborator

NCT04819438Phase 1Completed

Riluzole Orodispersible Film Replicate Bioavailability

Role: lead

NCT02858193Phase 1Completed

Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup

Role: collaborator

NCT02101281Phase 2Completed

Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye

Role: collaborator

NCT02350296Phase 1Completed

Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution

Role: collaborator

NCT02919072Phase 3Terminated

Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section

Role: collaborator

NCT05695157Not ApplicableUnknown

Clinical Performance and Safety of Suture-TOOL

Role: collaborator

NCT04932850Phase 1Completed

Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.

Role: collaborator

NCT05136521Phase 1Completed

Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions

Role: collaborator

NCT03428230Phase 2Completed

Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures

Role: collaborator

NCT04678076Phase 1Completed

Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution

Role: collaborator

NCT04670601Phase 1Completed

Bioequivalence of Flurbiprofen Lozenge vs Strepfen

Role: collaborator

NCT03706781Phase 1Completed

A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer

Role: collaborator

NCT01280175Phase 1Completed

Foster With or Without Charcoal Block or Aerochamber Plus

Role: collaborator

NCT03516630Phase 1Completed

Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers

Role: collaborator

NCT03821415Phase 2Completed

Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome

Role: collaborator

NCT02713893Phase 1Completed

Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream

Role: collaborator

NCT03216304Phase 1Completed

Safinamide Steady State Interaction With Rosuvastatin

Role: lead